chrX-137030573-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_054021.2(GPR101):c.1102G>A(p.Glu368Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000356 in 1,209,184 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 134 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_054021.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR101 | NM_054021.2 | c.1102G>A | p.Glu368Lys | missense_variant | 2/2 | ENST00000651716.2 | NP_473362.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR101 | ENST00000651716.2 | c.1102G>A | p.Glu368Lys | missense_variant | 2/2 | NM_054021.2 | ENSP00000498972.1 | |||
ENSG00000291054 | ENST00000693626.2 | n.394-29952C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000162 AC: 18AN: 111236Hom.: 0 Cov.: 23 AF XY: 0.0000898 AC XY: 3AN XY: 33406
GnomAD3 exomes AF: 0.000240 AC: 44AN: 183038Hom.: 0 AF XY: 0.000207 AC XY: 14AN XY: 67480
GnomAD4 exome AF: 0.000376 AC: 413AN: 1097948Hom.: 0 Cov.: 32 AF XY: 0.000361 AC XY: 131AN XY: 363318
GnomAD4 genome AF: 0.000162 AC: 18AN: 111236Hom.: 0 Cov.: 23 AF XY: 0.0000898 AC XY: 3AN XY: 33406
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2023 | The c.1102G>A (p.E368K) alteration is located in exon 1 (coding exon 1) of the GPR101 gene. This alteration results from a G to A substitution at nucleotide position 1102, causing the glutamic acid (E) at amino acid position 368 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 26, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at